McMillanS.C.Assessing and managing narcotic-induced constipation in adults with cancer.Cancer Control.2004; 11(3 suppl 1): 3–9.
2.
SmithS.Evidence-based management of constipation in the oncology patient.Eur J Oncol Nurs.2001; 5: 18–25.
3.
O'MahonyS., CoyleN., PayneR.Current management of opioid-related side effects.Oncology (Huntingt).2001; 15: 61–73, 77.
4.
ChoiY.S., BillingsA.J.Opioid antagonists: a review of their role in palliative care, focusing on use in opioid-related constipation.J Pain Symptom Manage.2002; 24: 71–90.
5.
WrightP.S., ThomasS.L.Constipation and diarrhea: the neglected symptoms.Semin Oncol Nurs.1995; 11: 289–297.
6.
SykesN.P.An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer.Palliat Med.1996; 10: 135–144.
7.
CurryC.E.,Tatum-ButlerD.Laxative products. In: CovingtonT.R., LawsonL.C., YoungL.L., eds. Handbook of Nonprescription Drugs.10th ed.Washington, DC: American Pharmaceutical Association; 1993: 219–236.
8.
LacyC.F.,ArmstrongL.L., GoldmanM.P., eds Drug Information Handbook.11th ed.Hudson, Ohio: Lexi-Comp Inc; 2003.
9.
SchillerL.R.Clinical pharmacology and use of laxatives and lavage solutions.J Clin Gastroenterol.1999; 28: 11–18.
10.
DoughtyD.B.When fiber is not enough: current thinking on constipation management.Ostomy Wound Manage.2002; 48: 30–41.
11.
ScarlettY.Medical management of fecal incontinence.Gastroenterology.2004; 126(1 suppl 1): S55–S63.
12.
GerberL., HicksJ., ShahJ.Rehabilitation of the cancer patient. In: DevitaV.T., HellmanS., RosenbergS.A., eds. Cancer: Principles and Practice of Oncology.6th ed.Baltimore, Md: Lippincott Williams & Wilkins; 2001: 3089–3110.
13.
FallonM., O'NeillB.ABC of palliative care: constipation and diarrhea.BMJ.1997; 315: 1293–1296.
14.
WongP.W., KadakiaS.How to deal with chronic constipation: a stepwise method of establishing and treating the source of the problem.Postgrad Med.1999; 106: 199–200, 203-204,207-210.
15.
ClevelandM.V., FlavinD.P., RubenR.A.New polyethylene glycol laxative for treatment of constipation in adults: a randomized, double-blind, placebo-controlled study.South Med J.2001; 94: 478–481.
16.
DoshS.A.Evaluation and treatment of constipation.J Fam Pract.2002; 51: 555–559.
17.
FoleyK.M.Supportive care and quality of life: management of cancer pain. In: DevitaV.T., HellmanS., RosenbergS.A., eds. Cancer: Principles and Practice of Oncology.6th ed.Baltimore, Md: Lippincott Williams & Wilkins; 2001: 2997–3011.
18.
AgraY., SacristanA., GonzalezM.Efficacy of senna versus lactulose in terminal cancer patients treated with opioids.J Pain Symptom Manage.1998; 15: 1–7.
19.
McNicolE., Horowicz-MehlerN., FiskR.A.Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review.J Pain.2003; 4: 231–256.
20.
ThomasJ., PortenoyM., MoehlC.A phase II randomized dose-finding trial of methylnaltrexone for the relief of opioid-induced constipation in hospice patients.Proc Annu Meet Am Soc Clin Oncol.2003; 22: 729. Abstract 2933.